Cargando…
Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome
Autores principales: | Breen, Ilana D., Brumfiel, Caitlin M., Patel, Meera H., Rosenthal, Allison C., Rule, William G., DiCaudo, David J., Craig, Fiona E., Pittelkow, Mark R., Mangold, Aaron R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873348/ https://www.ncbi.nlm.nih.gov/pubmed/33604439 http://dx.doi.org/10.1016/j.jdcr.2020.12.035 |
Ejemplares similares
-
Primary cutaneous epidermotropic marginal zone B-cell lymphoma treated with total skin electron beam therapy
por: Boudreaux, Blake W., et al.
Publicado: (2021) -
Successful treatment of Sezary syndrome with extracorporeal photopheresis – The first attempt in India
por: Tiwari, Aseem K., et al.
Publicado: (2019) -
A case of B-cell lymphoblastic leukemia cutis flaring following CAR T-cell therapy in a patient with refractory acute lymphoblastic leukemia
por: Puri, Pranav, et al.
Publicado: (2020) -
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome
por: Iselin, Christoph, et al.
Publicado: (2021) -
What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
por: Akilov, Oleg E.
Publicado: (2023)